Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Wheatley

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Cancer|September 4, 2023
The utility of H2 receptor antagonists in preventing infusion-related reactions to paclitaxel chemotherapyCorey Tsang, Jessica Robinson, Paul F Wheatley-Price, et al.
The Medical Journal of Australia|April 5, 1993
Recent military experience with malaria chemoprophylaxisK H Rieckmann, A E Yeo, D R Davis, et al.
Current Oncology (Toronto, Ont.)|November 26, 2024
Update on Practical Management of Early-Stage Non-Small Cell Lung Cancer (NSCLC): A Report from the Ontario ForumParneet K Cheema, Paul F Wheatley-Price, Matthew J Cecchini, et al.
Current Oncology (Toronto, Ont.)|December 13, 2021
Canadian Consensus Recommendations on the Management of <i>MET</i>-Altered NSCLCParneet K Cheema, Shantanu O Banerji, Normand Blais, et al.
Current Oncology (Toronto, Ont.)|July 28, 2023
Canadian Consensus Recommendations on the Management of Extensive-Stage Small-Cell Lung CancerBarbara L Melosky, Natasha B Leighl, David Dawe, et al.
Current Oncology (Toronto, Ont.)|July 28, 2023
Canadian Consensus Recommendations on the Management of KRAS G12C-Mutated NSCLCParneet K Cheema, Shantanu O Banerji, Normand Blais, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Cancer|September 4, 2023
The utility of H2 receptor antagonists in preventing infusion-related reactions to paclitaxel chemotherapyCorey Tsang, Jessica Robinson, Paul F Wheatley-Price, et al.
The Medical Journal of Australia|April 5, 1993
Recent military experience with malaria chemoprophylaxisK H Rieckmann, A E Yeo, D R Davis, et al.
Current Oncology (Toronto, Ont.)|November 26, 2024
Update on Practical Management of Early-Stage Non-Small Cell Lung Cancer (NSCLC): A Report from the Ontario ForumParneet K Cheema, Paul F Wheatley-Price, Matthew J Cecchini, et al.
Current Oncology (Toronto, Ont.)|December 13, 2021
Canadian Consensus Recommendations on the Management of <i>MET</i>-Altered NSCLCParneet K Cheema, Shantanu O Banerji, Normand Blais, et al.
Current Oncology (Toronto, Ont.)|July 28, 2023
Canadian Consensus Recommendations on the Management of Extensive-Stage Small-Cell Lung CancerBarbara L Melosky, Natasha B Leighl, David Dawe, et al.
Current Oncology (Toronto, Ont.)|July 28, 2023
Canadian Consensus Recommendations on the Management of KRAS G12C-Mutated NSCLCParneet K Cheema, Shantanu O Banerji, Normand Blais, et al.
Pageof 2